作者: Serge Adnot , Didier Branellec
DOI:
关键词: Vector (molecular biology) 、 Virology 、 Biology 、 Recombinant DNA 、 Nucleic acid 、 Pulmonary hypertension
摘要: The present invention relates to the use of a vector which comprises nucleic acid encoding an angiogenic factor for preventing, ameliorating or treating pulmonary hypertension. It also specific pharmaceutical compositions enable these vectors be administered locally and efficiently.